fda warning letters glp-1 compounders october 2025 Are weight loss compounds safe? Not from this San Francisco telehealth startup and its former supplier, whistleblowers say. @nbcbayarea #weinvestigate #glp1community #glp1 #weightlossjourney Dr. Elizabeth Kazarian, MD |

Description

By Month 4, as the body fully adjusts to the medication and metabolic adaptation occurs, up to 95% of patients report resolution

New Indications : GLP-1 drugs are being tested for obesity-related conditions (NASH/non-alcoholic steatohepatitis, cardiovascular risk reduction, etc.)

Cardiometabolic benefits, such as better blood pressure and cholesterol, can also fade over time once treatment is stopped Lingering side effects Side effects do not vanish immediately

Patients should verify whether their tier includes dosage increases, emergency consultations, or lab work if required for safety monitoring

Third, we did not account for earlier disease stages, such as advanced chronic kidney disease, nor did we account for side-effects of these medications